2008
DOI: 10.1016/j.micinf.2007.12.011
|View full text |Cite
|
Sign up to set email alerts
|

The antibacterial activity against MRSA strains and other bacteria of a <500 Da fraction from maggot excretions/secretions of Lucilia sericata (Diptera: Calliphoridae)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
77
1
3

Year Published

2009
2009
2020
2020

Publication Types

Select...
7
2
1

Relationship

1
9

Authors

Journals

citations
Cited by 100 publications
(89 citation statements)
references
References 29 publications
(21 reference statements)
5
77
1
3
Order By: Relevance
“…Escherichia coli) bacteria. 22 It is possible that the presence of antibacterial peptides in M. domestica larvae could be influential in the lack of retention of C. difficile through metamorphosis and although yet to be discovered in M. domestica, some insects (the Korean dung beetle, Copris tripartitus) do possess antimicrobial peptides (coprisin) with activity against vegetative cells of C. difficile. 23 …”
Section: Discussionmentioning
confidence: 99%
“…Escherichia coli) bacteria. 22 It is possible that the presence of antibacterial peptides in M. domestica larvae could be influential in the lack of retention of C. difficile through metamorphosis and although yet to be discovered in M. domestica, some insects (the Korean dung beetle, Copris tripartitus) do possess antimicrobial peptides (coprisin) with activity against vegetative cells of C. difficile. 23 …”
Section: Discussionmentioning
confidence: 99%
“…Adult blow flies oviposit in natural body orifices. Staphylococci are abundant in the oral cavity, upper respiratory tract and genital regions of the human body [28], with Staphylococcus aureus being found in nasal passages of 30% of the human population [29] and Escherichia coli is commonly found in the rectum area [28]. Both bacterial species have also been isolated from corpses during the first 72 hours after death [30][31].…”
Section: Representative Bacterial Speciesmentioning
confidence: 99%
“…Groups around the world have invested in research on new antibiotics and on different modes of action to fight pathogenic bacteria in humans (Bexfield et al, 2008;Rasko et al, 2008;Nigam et al, 2006;Tang et al, 2009;Van Den Berg et al, 2008;Bexfield et al, 2004); however, the possibility of applying such solutions in animals is very remote, and therefore, livestock production relies on the improvement of health conditions to obtain better results (Tabes, 2008).…”
Section: Additives and The Intestinal Microbiota: A New Perspectivementioning
confidence: 99%